Magna pars studiorum, prodita quaerimus. Phasellus laoreet lorem vel dolor tempus vehicula. Nec dubitamus multa iter quae et nos invenerat. Quisque placerat facilisis egestas cillum dolore.
Quisque ut dolor gravida, placerat libero vel, euismod. Quae vero auctorem tractata ab fiducia dicuntur.
Tackling Breast Cancer Health Disparities for Hispanics/Latinas
Learn More
Dragging Oncogenes From the Cell: A New Horizon for Targeting KRAS
Learn More
FDA’s Office of Hematology and Oncology Products Reorganizes
Learn More
Bladder Cancer: Burgeoning Beyond BCG
Learn More
Addressing the Promise and Challenges of Big Data
Learn More
Mammography Screening: Benefits and Potential Risks
Learn More
Exploring the Past, Present, and Future of Cancer Research
Learn More
FDA Approves New Treatments for Several Rare Cancers
Learn More
AACR Annual Meeting 2017: Challenging the Dogma of Treating IDH-mutant Cancers With IDH Inhibitors
Learn More
SABCS 2021: Understanding and Applying Liquid Biopsies
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: